GRACE

cancergrace.org

 

GRACE
M

Should Molecular Tests Be Considered in Stage 3 NSCLC and Would Outcome Effect Treatment Decisions?

By GRACE FEATURING Matthew Gubens, Jack West, Millie Das
By GRACE FEATURING Matthew Gubens, Jack West, Millie Das
324 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:38
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh
Lung
22:29

New

From Bench to Bedside: Genomic Discoveries Driving Lung Cancer Thera…

GRACE

T. Sen

21:58

New

Reading a Molecular Testing Report in Lung Cancer

GRACE

K. Yun

43 views
18:32

New

ALK, ROS1, and RET in NSCLC: Pushing the Boundaries of Targeted Ther…

GRACE

C. Bestvina

46 views
23:07

New

MET, NTRK and NRG1 Driven NSCLC

GRACE

A. Desai

25 views
19:57

New

Targeting KRAS and BRAF in NSCLC

GRACE

J. Nieva

26 views
13:49

New

EGFR and HER2 Targeted Therapies in NSCLC: New Developments and a Ch…

GRACE

X. Le

57 views
06:05

New

Patient Selection Strategies for Optimal Metastatic NSCLC Treatment

GRACE

P. Lyengar

16 views
03:50

New

LCT for Limited Metastatic NSCLC: NRG-LU002 Limitations & Summary

GRACE

P. Lyengar

09:35

New

LCT for Limited Metastatic NSCLC: NRG-LU002 Results

GRACE

P. Lyengar

05:45

New

Integrating Local Therapy in Metastatic NSCLC: Consolidation Focus

GRACE

P. Lyengar

08:43

New

Considerations for Local Treatment in Metastatic NSCLC

GRACE

P. Lyengar

06:18

Using Tarlatamab for Extensive Stage SCLC

GRACE

A. Desai, F. Abu Rous

89 views
05:40

Advancing Treatment in EGFR-Mutated NSCLC: Results From MARIPOSA2 an…

GRACE

A. Desai, F. Abu Rous

81 views
10:07

Advancing Treatment in EGFR-Mutated NSCLC: Results From FLAURA2 and …

GRACE

A. Desai, F. Abu Rous

154 views
17:13

Case-Based Panel: Managing EGFR Exon 21 L858R mNSCLC and Insights Fr…

GRACE

A. Saxena, E. Singhi, I. Preeshagul, N. Rohs

52 views
17:43

Case-Based Panel: Treating 70 y/o Female With SCLC and Insights From…

GRACE

E. Singhi, N. Rohs, A. Saxena, I. Preeshagul

143 views
18:45

Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights Fro…

GRACE

N. Rohs, A. Saxena, E. Singhi, I. Preeshagul

78 views
04:46

Repeat Biopsy in KRAS+ NSCLC

GRACE

J. Luo

96 views
05:27

Biopsies in Lung Cancer: Tumor vs. Liquid

GRACE

J. Luo

418 views
04:24

Treatment Strategies for KRAS+ NSCLC

GRACE

J. Luo

124 views
09:21

An Overview of KRAS+ NSCLC and Diagnostic Testing

GRACE

J. Luo

127 views
04:22

Targeted Therapy in Lung Cancer: Side Effects

GRACE

T. Patil

110 views
04:08

Targeted Therapy in Lung Cancer: The Importance of Biomarkers

GRACE

T. Patil

123 views
04:01

Lung Resection in Early Stage NSCLC: An Overview

GRACE

C. Jeffrey Yang

267 views
05:58

Future Goals of mNSCLC Treatment

GRACE

P. Iyengar

65 views
06:13

The NRG-LU Trial: Maintenance Systemic Therapy vs. Local Consolidati…

GRACE

P. Iyengar

61 views
06:14

Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC

GRACE

P. Iyengar

11 views
02:41

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

609 views
03:19

Biomarkers in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

205 views
06:09

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

413 views
03:25

Antibody Drug Conjugates and How They Are Used in NSCLC

GRACE

L. Bazhenova

34 views
02:36

ADC Treatment in NSCLC

GRACE

L. Bazhenova

26 views
03:15

Bispecific Antibodies in Lung Cancer

GRACE

L. Bazhenova

20 views
02:52

Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutatio…

GRACE

L. Bazhenova

41 views
05:47

Treatment Options for EGFR+ NSCLC

GRACE

I. Dagogo-Jack, N. Vokes

34 views
03:42

Surgical Options for Stage IV NSCLC With Brain Metastases: 60 y/o Wo…

GRACE

I. Dagogo-Jack, J. Reuss

18 views
06:02

Neoadjuvant Chemo +/- Nivo for Patients With Early Stage NSCLC: Case…

GRACE

I. Dagogo-Jack, J. Reuss

92 views
03:21

Treating Stage III NSCLC: Case-Based Panel Discussion

GRACE

I. Dagogo-Jack, K. Arbour

22 views
03:44

How Oncologists Stage Disease - Case-Based Panel Discussion: 50 y/o …

GRACE

I. Dagogo-Jack, J. Reuss, N. Vokes, K. Arbour

22 views
09:37

Is Broad NGS the Standard of Care in Advanced NSCLC?

GRACE

I. Dagogo-Jack, M. Marmarelis, A. Sacher, A. Hegde

135 views
05:27

Neoadjuvant Therapy vs. Adjuvant Therapy in NSCLC: What Is the Futur…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

107 views
05:38

Surgical vs. Nonsurgical Treatment in Early NSCLC

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

90 views
07:28

Early Stage NSCLC: PD-L1 and Durvalumab

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

86 views
04:35

Testing in Potentially Resectable & Unresectable Locally Advanced NS…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

100 views
22:49

The Need for Broad Molecular Testing for Driver Mutations in NSCLC

GRACE

J. Gainor

108 views
26:08

NSCLC Frontline Therapy for Uncommon Mutations: Overview of RET, NTR…

GRACE

J. Gainor

110 views
06:15

Expert Discussion on Targeted Therapy for mNSCLC: Can ALK Inhibitors…

GRACE

J. West

40 views
18:10

A Case of a NSCLC KRAS 71 y/o Female With Underlying Autoimmune Cond…

GRACE

S. Liu, J. Brahmer, B. Levy

78 views
15:42

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitini…

GRACE

J. Weiss

207 views
10:33

Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…

GRACE

Z. Piotrowska

115 views
18:15

Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …

GRACE

Z. Piotrowska

105 views
05:41

ASCO Expert Discussion on Malignant Pleural Mesothelioma: Does Durva…

GRACE

J. West, H. Yu, D. Spigel

31 views
05:47

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

GRACE

J. West, H. Yu, D. Spigel

105 views
10:25

IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? Wh…

GRACE

M. Das

69 views
08:13

2020 ASCO Highlights on RT+ Chemo in LS-SCLC: Is There a Difference …

GRACE

J. West, H. Yu, D. Spigel

65 views
16:22

2020 ASCO ADAURA Trial Update on Adjuvant Osimertinib in EGFR+ NSCLC…

GRACE

H. Yu, D. Spigel, J. West

196 views
11:28

2020 ASCO Update on 1L Advanced NSCLC: Is Nivo + Ipi + Limited Cours…

GRACE

H. Yu, D. Spigel, J. West

111 views
11:22

2020 ASCO Update on Advanced NSCLC: What Is the Role for Nivolumab/I…

GRACE

H. Yu, D. Spigel, J. West

131 views
09:02

2020 ASCO Update on MET/RET+ NSCLC: How Promising Are Capmatinib & P…

GRACE

H. Yu, D. Spigel, J. West

127 views
08:25

2020 ASCO Update on HER2+ NSCLC: Is There a Promising Clinical Activ…

GRACE

H. Yu, D. Spigel, J. West

20 views
12:16

2020 ASCO Update on EGFR+ NSCLC: Does Upfront SBRT to Sites at Diagn…

GRACE

H. Yu, D. Spigel, J. West

572 views
08:16

ASCO 2020 Updates on PD-L1 NSCLC: Is Tiragolumab+Atezo Beneficial fo…

GRACE

J. West, H. Yu, D. Spigel

79 views
05:32

2020 Updates on SCLC: Have We Progressed in the Treatment of Relapse…

GRACE

T. Owonikoko

230 views
05:16

Liquid Biopsy in NSCLC: Does Adding Liquid Biopsy to Tissue Testing …

GRACE

C. Aggarwal

273 views
06:45

SCLC Updates: What Are the Leading Immunotherapy Options?

GRACE

S. Liu

315 views
05:38

Expert Discussion on mNSCLC: What Are the Leading Treatment Options …

GRACE

S. Liu

342 views
05:45

2020 Update on Molecular Abnormalities in NSCLC: How Do MET Exon 14 …

GRACE

J. Bauml

251 views
05:56

The Role of IO for NSCLC Patients With Driver Mutations: What Data D…

GRACE

B. Levy

197 views
07:43

2020 Update on Targeted Therapies in NSCLC PD-L1 Expression: What Ar…

GRACE

M. Das

113 views
07:55

Non-Small Cell Lung Cancer: Is Immunotherapy Safe for Frail Patients…

GRACE

M. Gubens

63 views
05:13

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

GRACE

M. Das

212 views
06:15

Non-Small Cell Lung Cancer: How Does a Positive HER2 Mutation Affect…

GRACE

J. West, J. Riess, S. Padda

21 views
06:03

ALK+ NSCLC With High PD-L1. What Is the First Line Treatment for Pot…

GRACE

J. West, J. Riess, S. Padda

137 views
06:00

What Is the Importance of MET Amplification Level in EGFR+ NSCLC Wit…

GRACE

C. McCoach, H. Wakelee, J. West

13 views
03:45

NSCLC EGFR Mutation Treated With Tagrisso: Progression While on Trea…

GRACE

C. McCoach, H. Wakelee, J. West

13 views
07:30

NSCLC EGFR Mutation and the FLAURA Trial: Is There a Difference in D…

GRACE

C. McCoach, H. Wakelee, J. West

17 views
08:20

EGFR + NSCLC: Is There a Place for Chemo and the Inclusion of Immuno…

GRACE

J. West, H. Wakelee, C. McCoach

748 views
04:14

EGFR Mutation and High and High PD-L1 in NSCLC: What is the Role of …

GRACE

C. McCoach, H. Wakelee, J. West

18 views
05:18

Non-Small Cell Lung Cancer: What Are the Recommended Treatments for …

GRACE

C. McCoach, H. Wakelee, J. West

127 views
05:04

NSCLC With EGFR Mutation: What Are the Treatment Options with Oligop…

GRACE

C. McCoach, H. Wakelee, J. West

13 views
07:12

NSCLC With EGFR Mutation: Is There a Place for Chemotherapy and an E…

GRACE

C. McCoach, H. Wakelee, J. West

527 views
05:52

NSCLC With EGFR Uncommon Exon 20 Mutation: Suggested Treatments, Tar…

GRACE

C. McCoach, H. Wakelee, J. West

20 views
04:20

The Challenges of Potential Pneumonitis Following Durvalumab in Stag…

GRACE

M. Gubens, J. West, M. Das

21 views
06:03

Would IO Be Beneficial for Stage 3 NSCLC Patient with PDL1-0 After S…

GRACE

M. Gubens, J. West, M. Das

136 views
08:02

Best Schedule for Durvalumab for Older Patient in Stage 3 NSCLC Afte…

GRACE

J. West, M. Gubens, M. Das

235 views
05:12

Unresectable NSCLC: What Is TMB and Does it Add Significant Benefit …

GRACE

M. Gubens, J. West, M. Das

481 views
08:50

Does Checkmate 227's Suggestion of an IO Combination of Ipi + Nivo O…

GRACE

M. Gubens, J. West, M. Das

132 views
10:58

Should Molecular Tests Be Considered in Stage 3 NSCLC and Would Outc…

GRACE

M. Gubens, J. West, M. Das

324 views
09:22

Case of 60 y/o Woman with ALK Positive Metastatic NSCLC: Approach to…

GRACE

S. Padda, J. Riess, J. West

200 views
06:14

Case of ALK Positive Patient with Asymptomatic Brain Metastases: Is …

GRACE

S. Padda, J. Riess, J. West

23 views
09:45

Treatment for NSCLC Patient Who Developed Resistance to ALK Inhibito…

GRACE

S. Padda, J. Riess, J. West

21 views
11:11

Is the Standard Treatment the Best Approach for Stage 3 Frail Patien…

GRACE

M. Gubens, J. West, M. Das

399 views
06:43

Should We Continue the ALK Inhibitor in NSCLC Patient with Brain Met…

GRACE

S. Padda, J. Riess, J. West

129 views
10:53

Is There a Role for Combination Therapies Like Chemo/Radio and IO fo…

GRACE

S. Padda, J. Riess, J. West

347 views
09:53

Stage 3 NSCLC - Standard Concurrent Chemo + Radiation, Followed by I…

GRACE

M. Gubens, J. West, M. Das

176 views
11:27

Stage 3 NSCLC: Is the Standard Treatment of Chemo and Radiation Foll…

GRACE

M. Gubens, J. West, M. Das

281 views
11:26

Case Based Discussion on Stage 3 NSCLC: Should We Do Molecular Tests…

GRACE

M. Gubens, J. West, M. Das

353 views
05:24

CancerGRACE's ASCO 2019 Update on Lung Cancer: How Promising is Lurb…

GRACE

J. West, B. Levy, C. Aggarwal

880 views
05:32

CancerGRACE's ASCO 2019 Update on Lung Cancer: Short Discussion on K…

GRACE

J. West, B. Levy, C. Aggarwal

179 views
06:02

CancerGRACE's ASCO 2019 Update on Lung Cancer: Circulating Tumor DNA…

GRACE

J. West, B. Levy, C. Aggarwal

100 views
05:53

CancerGRACE's ASCO 2019 Update on Lung Cancer: Retrospective Analysi…

GRACE

J. West, B. Levy, C. Aggarwal

102 views
03:55

CancerGRACE's ASCO 2019 Update on Stage IV NSCLC: New Targets - RET

GRACE

J. West, B. Levy, C. Aggarwal

150 views
06:33

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

288 views
07:14

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

70 views
06:33

CancerGRACE's 2019 ASCO Highlights in Advanced NSCLC: What is the Lo…

GRACE

J. West, B. Levy, C. Aggarwal

225 views
06:38

CancerGRACE's 2019 ASCO Highlights on Adjuvant Afatinib in Stage II …

GRACE

J. West, B. Levy, C. Aggarwal

471 views
07:26

CancerGRACE's 2019 ASCO Highlights on Stage I NSCLC Adjuvant Chemoth…

GRACE

J. West, B. Levy, C. Aggarwal

27 views
21:24

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views
47:56

Initial Treatment and Acquired Resistance in Advanced Lung Cancer & …

GRACE

J. Bauml, J. Sabari

209 views
21:58

Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

J. Bauml

16 views
19:19

Introduction to Next Generation Sequencing in Metastatic Lung Cancer…

GRACE

J. Bauml

633 views
23:26

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views
09:30

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

34 views
07:53

Optimal First Line Treatment of EGFR+ Advanced NSCLC: First and Seco…

GRACE

J. West

115 views
18:32

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Osimertinib vs…

GRACE

J. West

566 views
17:04

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Dacomitinib, E…

GRACE

J. West

680 views
17:10

Targeted Therapies in Advanced Lung Cancer: What is the Role of Rebi…

GRACE

H. Borghaei

464 views
26:54

Discussion/Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

H. Borghaei

25 views
15:23

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Opt…

GRACE

C. Aggarwal

623 views
02:13

Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

GRACE

K. Kelly

172 views
01:54

Tumor Mutation Burden in Patients with Non-Squamous NSCLC: Current S…

GRACE

S. Patel

25 views
02:41

Evolving Standards for Molecular Testing in Advanced NSCLC

GRACE

S. Patel

25 views
02:05

Combinations of Immunotherapy Agents in Advanced NSCLC: Current Stat…

GRACE

S. Patel

20 views
02:17

The Basics of Managing Immune-Mediated Side Effects in NSCLC

GRACE

S. Patel

29 views
03:50

What Should Patients With Rapid Progression in Advanced NSCLC Throug…

GRACE

J. West

194 views
04:46

"Consolidation" Radiation After a Good Response to First Line Therap…

GRACE

J. West

16 views
06:57

Chemotherapy and Immunotherapy Combinations in Advanced Non-Squamous…

GRACE

J. West

168 views
05:39

Chemo Immuno Therapy Combinations in Advanced Squamous NSCLC

GRACE

J. West

183 views
07:13

Does Immunotherapy Work in Patients with Driver Mutations Like EGFR …

GRACE

J. West

238 views
04:09

EGFR TKI Gilotrif(Afatinib) in Metastatic Squamous NSCLC

GRACE

V. Velcheti

202 views
04:24

Lung Cancer Immunotherapy- Is There Anything Better than PDL1

GRACE

V. Velcheti

116 views
03:20

MET as a Target in Advanced NSCLC

GRACE

V. Velcheti

25 views
04:33

The Changing Landscape of 1L Treatment of ALK-Positive Advanced NSCL…

GRACE

A. Shaw

46 views
06:02

Patterns of Resistance in ALK Positive NSCLC

GRACE

A. Shaw

229 views
05:04

Controlling Brain Metastases in Patients with Molecular Driven Advan…

GRACE

A. Shaw

34 views
02:14

Immunotherapy for Previously Treated Patients with NSCLC

GRACE

K. Reckamp

17 views
04:50

New Options in Acquired Resistance for ALK+ Metastatic Non-small Cel…

GRACE

N. Pennell

237 views
03:45

The Role for Immunotherapy in Patients with a Driver Mutation Lung C…

GRACE

N. Pennell

20 views
03:35

Liquid Biopsies for Broad Genomic Testing in Lung Cancer

GRACE

N. Pennell

36 views
03:53

Liquid Biopsies for EGFR T790M Advanced NSCLC

GRACE

N. Pennell

21 views
02:45

The Role of Angiogenesis in Previously Treated NSCLC

GRACE

K. Reckamp

21 views
09:07

Advanced Non Squamous NSCLC, High PD-L1, No Mutation - Optimal 1st L…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

220 views
12:59

Advanced Non Squamous NSCLC, Low PD-L1, No Mutation - Best Systemic …

GRACE

J. West, Z. Piotrowska, T. Owonikoko

237 views
11:09

Case Based Panel Discussion - Fit Patient Adv Squamous NSCLC Low Tum…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

16 views
08:18

Lung Cancer Case Based Panel Discussion - EGFR and High PDL-1, Choos…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

151 views
09:21

Case Based Panel Discussions - Metastatic Squamous NSCLC Low Tumor P…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

17 views
08:17

Rapid Progression Lung Adenocarcinoma High PD-L1 - How Do You Treat?…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

72 views
11:15

ASCO 2018 - Keynote 042 - Keytruda as a Single Agent Compared to Dou…

GRACE

K. Kelly, J. West, S. Patel

359 views
12:26

ASCO 2018 - Potential Showdown of Two Positive Trials? Keynote 407 a…

GRACE

K. Kelly, J. West, S. Patel

25 views
11:29

ASCO 2018 Keynote189 - Cisplatin or Carboplatin with Alimta & Keytru…

GRACE

K. Kelly, J. West, S. Patel

23 views
09:40

ASCO 2018 - Checkmate 227 - Combinations of Nivolumab and Ipilimumab…

GRACE

K. Kelly, J. West, S. Patel

25 views
07:35

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer…

GRACE

K. Kelly, J. West, S. Patel

15 views
09:11

ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Pos…

GRACE

K. Kelly, J. West, S. Patel

17 views
06:27

ASCO 2018 - Tarceva Combined with Carboplatin & Alimta - Given Upfro…

GRACE

K. Kelly, J. West, S. Patel

19 views
02:52

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the …

GRACE

K. Kelly, J. West, S. Patel

24 views
03:34

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated, Now Relaps…

GRACE

K. Kelly, J. West, S. Patel

19 views
04:26

ASCO 2018 - Dream Study - Chemo with Imfinzi (durvalumab) for Mesoth…

GRACE

K. Kelly, J. West, S. Patel

32 views
25:01

OncTalk 2018 - Newer Technologies in Radiation - Local Therapies for…

GRACE

V. Mehta

21 views
21:07

OncTalk 2018 - Novel Indications for Local Therapy in Adv NSCLC - Lo…

GRACE

P. Iyengar

9 views
19:01

NSCLC - Local Therapies for Metastatic LC

GRACE

E. Vallieres

203 views
27:13

OncTalk 2018 - Systemic Therapies for Advanced NSCLC - Local Therapi…

GRACE

J. West

23 views
45:31

OncTalk 2018 - Panel Discussion and Q&A - Local Therapies for Metast…

GRACE

E. Vallieres, J. West, V. Mehta, P. Iyengar

16 views